— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Putting the spotlight on membranous nephropathy
The Halpin Foundation and the American Society of Nephrology (ASN) proudly highlight the research advances in membranous nephropathy made possible by The Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers. This award provides recipients transition funding toward successful application for an NIH RO1 grant.
Elena Torban, PhD (McGill University Faculty of Medicine), the 2008 recipient of The Halpin Foundation-ASN Research Grant, recently explained, 'The generous financial two-year support provided by The Halpin Foundation has enabled us to conduct a successful experimental program demonstrating for the first time that podocyte architecture is indeed regulated by the PCP pathway. We also showed that the podocyte-specific protein, nephrin, is linked to proteins of the PCP network. This finding establishes a mechanism whereby the PCP pathway regulates nephrin-dependent organisation of foot processes.'
The 2009 recipient of The Halpin Foundation Laurence H. Beck, Jr., MD, PhD wrote of the grant, 'The funding provided by the Halpin Foundation has been instrumental in allowing my research to take root and grow. The research award has permitted me to spend the majority of these two years in the laboratory, performing experiments and helping to train young scientists and fellows conduct similar lines of inquiry. The fruits of this research should soon allow me to successfully apply for individual federal funding. Their ongoing interactions with leaders in this field on a national and international level have been enormously helpful for me in terms of forming productive collaborations to move this research forward. I will always be grateful for this support at such a critical time in the career of a young physician-scientist.'
Dr Beck and several colleagues will also participate in a Clinical Nephrology Conference (CNC) during Renal Week entitled, 'Membranous Nephropathy' on Friday, November 19 from 10:30 am - 12:30 pm in Korbel 2A/3A of the Colorado Convention Centre in Denver, CO. The session, 'The Human Membranous Antibody: Mechanism and Monitoring' is a way to highlight research advances and stimulate investigations regarding membranous nephropathy.
The Halpin Foundation has dedicated itself to the study of membranous nephropathy since 1989, after the Halpins' 14-year-old son was diagnosed with this rare disorder. To advance research of the disorder and its symptoms, including loss of protein in the urine and a progressive decline in renal function, The Halpin Foundation partnered with the American Society of Nephrology (ASN) to promote research relevant to membranous nephropathy in 2004.
The foundation is committed to advancing the medical community's understanding of membranous nephropathy, including whether there is a hereditary predisposition to the disease. In addition, The Halpin Foundation works to raise awareness of membranous nephropathy in the scientific and lay communities.
'We are grateful to The Halpin Foundation for helping us fund new investigators interested in studying this disease to answer the many unanswered questions surrounding membranous nephropathy and nephrotic syndrome, said ASN's President, Sharon Anderson, MD, FASN.
Joan Halpin, President of the Halpin Foundation, is hopeful this program will 'attract a diverse audience that will be encouraged to devote time and intellect to the consideration of the pathogenesis and therapy for this disorder.'
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
MTV survey cranks up the volume on loud music's impact on hearing
New method may accelerate drug discovery for difficult diseases like Parkinson's
Caffeine reverses memory impairment in Alzheimer's mice
Site for alcohol's action in the brain discovered